All In Biotech

Drug Trial Radar · NCT02601885

A Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis

An Escalating Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis

Last checked: Nov 19, 2026Latest source record: May 17, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

20

Actual

Start

Oct 18, 2016

Primary completion

Apr 20, 2018

Study completion Apr 20, 2018

Sponsor

Lead sponsor
AbbVieAbbVie (ABBV)
Sponsor type
Industry
First posted
Nov 11, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 60 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study seeks to evaluate the safety, tolerability, pharmacokinetics (PK) and immunogenicity of ABT-555 in participants with relapsing forms of multiple sclerosis (RFMS).

Conditions

  • Multiple Sclerosis

Interventions

  • ABT-555Drug

    Intravenous Infusion

  • PlaceboOther

    Intravenous Infusion

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number and percentage of participants reporting adverse eventsTime frame: Throughout study from Day 1 to Day 176
  2. Concentration of anti-drug antibody (ADA) titers of ABT-555Time frame: Day 1 to Day 176
  3. Time to Maximum observed plasma concentration (Tmax) of ABT-555Time frame: Day 1 to Day 176
  4. Maximum observed plasma concentration (Cmax) of ABT-555Time frame: Day 1 to Day 176
  5. Area under the concentration curve (AUC) of ABT-555Time frame: Day 1 to Day 176

Locations

8 sites in 1 country. Site status is shown where the registry gives one.

  • Compass Research LLC

    Orlando, Florida

  • Rowe Neurology Institute

    Lenexa, Kansas

  • Parexel International

    Baltimore, Maryland

  • MIND

    Farmington Hills, Michigan

  • Duke Univ Med Ctr

    Durham, North Carolina

  • Tri-State Mountain Neurology

    Johnson City, Tennessee

  • Clinical Trial Network

    Houston, Texas

  • Integrated Neurology Services

    Alexandria, Virginia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.